Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome
- PMID: 33952771
- DOI: 10.7883/yoken.JJID.2021.046
Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome
Abstract
Severe acute respiratory syndrome coronavirus 2 has infected over 100 million people since it appeared in Wuhan, China, just one year ago. This study aimed to evaluate the relationship between interleukin-6 (IL-6) gene polymorphisms -174G/C and -597G/A and coronavirus disease 2019 (COVID-19) course. The study included 70 patients aged 18-45 years who were diagnosed with COVID-19 in Turkey between March and November 2020 and hospitalized in our hospital. Of these, 40 patients required intensive care admission due to macrophage activation syndrome (MAS), and 30 patients did not develop MAS or acute respiratory distress syndrome. The frequencies of the IL-6-174G/C and -597G/A polymorphisms were determined. There were significant differences between the groups in terms of the -174G/C allele and genotype frequency according to the Hardy-Weinberg equilibrium (χ2 = 10.029, df = 1, P = 0.002 and χ2 = 9.998, df = 1, P = 0.002, respectively). The frequency of the GG genotype was significantly higher in the MAS group than in the non-MAS group (P = 0.002). The G allele was also significantly more frequent in the MAS group than in the non-MAS group (P = 0.032). Analysis of the -174G/C polymorphism in patients with MAS showed that the G allele may be a risk factor for increased serum IL-6 levels and progression to MAS.
Keywords: COVID-19; interleukin-6; macrophage activation syndrome; polymorphism.
Similar articles
-
Genetic polymorphisms of IL6 gene -174G > C and -597G > A are associated with the risk of COVID-19 severity.Int J Immunogenet. 2023 Feb;50(1):5-11. doi: 10.1111/iji.12605. Epub 2022 Nov 2. Int J Immunogenet. 2023. PMID: 36323530 Free PMC article.
-
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.J Med Virol. 2021 Dec;93(12):6653-6659. doi: 10.1002/jmv.27238. Epub 2021 Jul 31. J Med Virol. 2021. PMID: 34314051 Free PMC article.
-
The Interleukin-6 gene variants may protect against SARS-CoV-2 infection and the severity of COVID-19: a case-control study in a Moroccan population.BMC Med Genomics. 2024 May 23;17(1):139. doi: 10.1186/s12920-024-01911-w. BMC Med Genomics. 2024. PMID: 38783290 Free PMC article.
-
Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis.Arch Dermatol Res. 2014 Mar;306(2):173-80. doi: 10.1007/s00403-013-1406-x. Epub 2013 Aug 28. Arch Dermatol Res. 2014. PMID: 23982631
-
Association between IL-6 -174G/C polymorphism and acute rejection of renal allograft: evidence from a meta-analysis.Transpl Immunol. 2012 Jan;26(1):11-8. doi: 10.1016/j.trim.2011.10.003. Epub 2011 Oct 17. Transpl Immunol. 2012. PMID: 22024650 Review.
Cited by
-
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors.Front Immunol. 2022 Jun 10;13:912336. doi: 10.3389/fimmu.2022.912336. eCollection 2022. Front Immunol. 2022. PMID: 35757770 Free PMC article. Review.
-
Macrophage Activation Syndrome in Viral Sepsis.Viruses. 2024 Jun 22;16(7):1004. doi: 10.3390/v16071004. Viruses. 2024. PMID: 39066167 Free PMC article. Review.
-
SARS-CoV-2 Infection and Candidate Biomarkers.Eurasian J Med. 2022 Dec;54(Suppl1):16-22. doi: 10.5152/eurasianjmed.2022.22305. Eurasian J Med. 2022. PMID: 36655440 Free PMC article.
-
Review of Medical Studies on COVID-19 During the Pandemic Period.Eurasian J Med. 2022 Dec;54(Suppl1):154-158. doi: 10.5152/eurasianjmed.2022.22336. Eurasian J Med. 2022. PMID: 36655460 Free PMC article.
-
Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.BMC Genom Data. 2021 Nov 14;22(1):49. doi: 10.1186/s12863-021-01001-1. BMC Genom Data. 2021. PMID: 34775962 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous